&nbsp;

Dec 1969

Drug

leuprolide

Other Name(s): Lupron® (AbbVie) , Lupron Depot® (AbbVie) , Eligard® (Sanofi Aventis)

Quick Link(s):

Dec 1969

Drug

lomustine

Other Name(s): CeeNU®

Quick Link(s):

Dec 1969

Drug

lenvatinib

Other Name(s): Lenvima®

Quick Link(s):

Sep 2023

Drug

lanreotide

Other Name(s): Somatuline® Autogel®

Quick Link(s):

Dec 1969

Drug

liposomal irinotecan

Other Name(s): Onivyde® (Baxalta Canada)

Quick Link(s):

Sep 2017

Regimen

LETR

Cancer Type:

Breast

Intent: Adjuvant

Funding:

ODB - General Benefit

letrozole

Drugs Used:

letrozole

Quick Link(s):

Regimen Monograph

Nov 2020

Regimen

LETR

Cancer Type:

Breast

Intent: Palliative

Funding:

ODB - General Benefit

letrozole

Drugs Used:

letrozole

Quick Link(s):

Regimen Monograph

Nov 2020

Regimen

LENA

Cancer Type:

Hematologic,

Myelodysplastic Syndrome (MDS)

Intent: Palliative

Funding:

ODB Limited Use

lenalidomide - For the treatment of patients with anemia due to myelodysplastic syndrome (MDS), according to clinical criteria

Drugs Used:

lenalidomide

Quick Link(s):

Regimen Monograph

Regimen

LOMU

Cancer Type:

Central Nervous System

Intent: Palliative

Funding:

ODB - General Benefit

lomustine

Drugs Used:

lomustine

Quick Link(s):

Regimen Monograph

Regimen

LPRL

Cancer Type:

Genitourinary,

Prostate

Intent: Neoadjuvant, Adjuvant, Palliative

Funding:

ODB - General Benefit

leuprolide - long-acting formulation

Drugs Used:

leuprolide

Quick Link(s):

Regimen Monograph

Regimen

LPRL

Cancer Type:

Breast

Intent: Adjuvant, Palliative

Funding:

ODB - General Benefit

leuprolide - long-acting formulation

ODB - General Benefit

leuprolide - long-acting formulation

Drugs Used:

leuprolide